• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Penetration of ceftriaxone into the middle ear fluid of children.

作者信息

Gudnason T, Gudbrandsson F, Barsanti F, Kristinsson K G

机构信息

Department of Pediatrics and Microbiology, National University Hospital (Landspitalinn) of Iceland, Reykjavik.

出版信息

Pediatr Infect Dis J. 1998 Mar;17(3):258-60. doi: 10.1097/00006454-199803000-00022.

DOI:10.1097/00006454-199803000-00022
PMID:9535262
Abstract
摘要

相似文献

1
Penetration of ceftriaxone into the middle ear fluid of children.头孢曲松在儿童中耳液中的渗透情况。
Pediatr Infect Dis J. 1998 Mar;17(3):258-60. doi: 10.1097/00006454-199803000-00022.
2
Penetration of ceftazidime into middle ear fluid in children with otitis media with effusion.
Laryngoscope. 1998 May;108(5):662-4. doi: 10.1097/00005537-199805000-00007.
3
Penetration of cefprozil into middle ear fluid of patients with otitis media.头孢丙烯在中耳炎患者中耳液中的渗透情况。
Antimicrob Agents Chemother. 1994 Sep;38(9):2210-2. doi: 10.1128/AAC.38.9.2210.
4
Penetration of cefpodoxime into middle ear fluid in pediatric patients with acute otitis media.
Pediatr Infect Dis J. 1997 Jan;16(1):79-81. doi: 10.1097/00006454-199701000-00020.
5
Cefprozil concentrations in middle ear fluid of children with acute otitis media.
Pediatr Infect Dis J. 2000 Mar;19(3):268-70. doi: 10.1097/00006454-200003000-00026.
6
Middle ear effusion concentrations of cefixime during acute otitis media with effusion and otitis media with effusion.
Pediatr Infect Dis J. 1997 Aug;16(8):816-7. doi: 10.1097/00006454-199708000-00016.
7
Penetration of cefaclor to adenoid tissue and middle ear fluid in secretory otitis media.
Scand J Infect Dis Suppl. 1983;39:48-52.
8
Studies on middle ear effusions.
Laryngoscope. 1982 Mar;92(3):287-91. doi: 10.1288/00005537-198203000-00012.
9
Penetration of cefprozil to middle ear effusion in children with chronic otitis media with effusion.
Int J Pediatr Otorhinolaryngol. 2003 Sep;67(9):965-8. doi: 10.1016/s0165-5876(03)00163-0.
10
Middle ear effusion amoxicillin concentrations in acute otitis media.
Pediatr Infect Dis J. 1998 Jul;17(7):657-8. doi: 10.1097/00006454-199807000-00019.

引用本文的文献

1
Antibiotics for Post-Tonsillectomy Morbidity: Comparative Analysis of a Single Institutional Experience.扁桃体切除术后发病率的抗生素治疗：单机构经验的比较分析
J Clin Med Res. 2016 May;8(5):385-8. doi: 10.14740/jocmr2523w. Epub 2016 Mar 20.
2
Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatrics.儿童抗生素剂量优化：药代动力学/药效学在儿科中的应用
Int J Antimicrob Agents. 2014 Mar;43(3):223-30. doi: 10.1016/j.ijantimicag.2013.11.006. Epub 2013 Dec 17.
3
High dose amoxicillin: Rationale for use in otitis media treatment failures.
大剂量阿莫西林：用于治疗中耳炎失败的理论依据。
Paediatr Child Health. 1999 Jul;4(5):321-3. doi: 10.1093/pch/4.5.321.
4
Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.头孢曲松：其在社区获得性感染和医院感染管理中应用的最新情况
Drugs. 2002;62(7):1041-89. doi: 10.2165/00003495-200262070-00005.
5
Current Concepts of Therapy for Otitis Media.
Curr Infect Dis Rep. 1999 Apr;1(1):22-26. doi: 10.1007/s11908-999-0005-7.
6
Management of acute otitis media in the 1990s: the decade of resistant pneumococcus.20世纪90年代急性中耳炎的管理：肺炎球菌耐药的十年。
Paediatr Drugs. 1999 Jan-Mar;1(1):31-50. doi: 10.2165/00128072-199901010-00004.
7
Eradication by ceftriaxone of Streptococcus pneumoniae isolates with increased resistance to penicillin in cases of acute otitis media.在急性中耳炎病例中，头孢曲松对青霉素耐药性增加的肺炎链球菌分离株的根除作用。
Antimicrob Agents Chemother. 1999 Jan;43(1):16-20. doi: 10.1128/AAC.43.1.16.
8
Management of infections due to antibiotic-resistant Streptococcus pneumoniae.耐抗生素肺炎链球菌所致感染的管理
Clin Microbiol Rev. 1998 Oct;11(4):628-44. doi: 10.1128/CMR.11.4.628.